Tuberculosis in Catastrophic Antiphospholipid Antibody Syndrome.

Indian Pediatr

Department of Pediatrics, Jupiter Hospital, Thane, Maharashtra, India.

Published: January 2021

Download full-text PDF

Source

Publication Analysis

Top Keywords

tuberculosis catastrophic
4
catastrophic antiphospholipid
4
antiphospholipid antibody
4
antibody syndrome
4
tuberculosis
1
antiphospholipid
1
antibody
1
syndrome
1

Similar Publications

Despite global efforts to end tuberculosis (TB), the goal of preventing catastrophic health expenditure (CHE) due to TB remains unmet. This cross-sectional study was conducted in Guizhou Province, Southwest China. Data were collected from the Hospital Information System and a survey of TB patients who had completed standardized antituberculosis treatment between January and March 2021.

View Article and Find Full Text PDF

Background: Tuberculosis (TB) poses a significant social and economic burden to households of persons with TB (PwTB). Despite free diagnosis and care under the National TB Elimination Programme (NTEP), individuals often experience significant out-of-pocket expenditure and lost productivity, causing financial catastrophe. We estimated the costs incurred by the PwTB during TB care and identified the factors associated with the costs.

View Article and Find Full Text PDF
Article Synopsis
  • Tuberculosis (TB) remains a significant health issue in China, with Bone-TB being a common form that complicates diagnosis due to symptom similarity to other conditions, resulting in delayed treatment.
  • This study analyzed data from 2,191 Bone-TB patients in Southwest China over a 12-year period, revealing demographic trends that highlight males, farmers, individuals aged 42-68, and those with HIV or diabetes as high-risk groups.
  • Findings indicate a slow increase in Bone-TB cases, primarily affecting the thoracic and lumbar spine, with drug-resistant cases and hospitalization costs also noted, emphasizing the need for targeted prevention and treatment strategies.
View Article and Find Full Text PDF

COVID-19 affected millions of people worldwide, and tuberculosis (TB) continues to affect millions of people each year. The combined pandemic of COVID-19 and TB had a catastrophic effect on healthcare policies and healthcare setups around the globe. The clinical profile and factors affecting the outcome of COVID-19 disease in TB patients on treatment in field conditions have not been studied in detail.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examined the financial burden of tuberculosis (TB) on patients in Myanmar, particularly those utilizing private providers in public-private mix (PPM) schemes, despite TB services being generally free.
  • - A survey of 695 adults revealed that patients incurred a median total cost of approximately $53.4 for TB treatment, with the most significant expenses occurring during the pre-treatment phase and clinic visits.
  • - Alarmingly, about 34.5% of patients faced catastrophic health expenditure, defined as spending over 20% of their financial capacity on TB-related costs, highlighting the ongoing economic challenges despite available healthcare services.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!